These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25823008)

  • 1. Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties.
    Anitua E; Zalduendo M; Troya M; Padilla S; Orive G
    PLoS One; 2015; 10(3):e0121713. PubMed ID: 25823008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: evaluation of the effect of leukocyte inclusion.
    Anitua E; Zalduendo MM; Prado R; Alkhraisat MH; Orive G
    J Biomed Mater Res A; 2015 Mar; 103(3):1011-20. PubMed ID: 24890049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in promoting repair of bone defects.
    Yin W; Qi X; Zhang Y; Sheng J; Xu Z; Tao S; Xie X; Li X; Zhang C
    J Transl Med; 2016 Mar; 14():73. PubMed ID: 26980293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrifugation Conditions in the L-PRP Preparation Affect Soluble Factors Release and Mesenchymal Stem Cell Proliferation in Fibrin Nanofibers.
    Melo BAG; Luzo ÂCM; Lana JFSD; Santana MHA
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31357568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release kinetic of pro- and anti-inflammatory biomolecules from platelet-rich plasma and functional study on osteoarthritis synovial fibroblasts.
    Mariani E; Roffi A; Cattini L; Pulsatelli L; Assirelli E; Krishnakumar GS; Cenacchi A; Kon E; Filardo G
    Cytotherapy; 2020 Jul; 22(7):344-353. PubMed ID: 32327304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Bielecki T; Jimbo R; Barbé G; Del Corso M; Inchingolo F; Sammartino G
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1145-52. PubMed ID: 21740377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.
    Sundman EA; Cole BJ; Fortier LA
    Am J Sports Med; 2011 Oct; 39(10):2135-40. PubMed ID: 21846925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inclusion of leukocytes into platelet rich plasma reduces scaffold stability and hinders extracellular matrix remodelling.
    Anitua E; Zalduendo M; Troya M; Tierno R; Alkhraisat MH
    Ann Anat; 2022 Feb; 240():151853. PubMed ID: 34767933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/Fibrin (L-PRP/L-PRF): new perspectives.
    Cieslik-Bielecka A; Dohan Ehrenfest DM; Lubkowska A; Bielecki T
    J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):43S-52S. PubMed ID: 23648198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of leukocyte- and platelet-rich plasma and pure platelet-rich plasma for cartilage regeneration.
    Xu Z; Yin W; Zhang Y; Qi X; Chen Y; Xie X; Zhang C
    Sci Rep; 2017 Mar; 7():43301. PubMed ID: 28265109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial.
    Madurantakam P; Yoganarasimha S; Hasan FK
    J Vis Exp; 2015 Sep; (103):. PubMed ID: 26485642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages of Pure Platelet-Rich Plasma Compared with Leukocyte- and Platelet-Rich Plasma in Treating Rabbit Knee Osteoarthritis.
    Yin WJ; Xu HT; Sheng JG; An ZQ; Guo SC; Xie XT; Zhang CQ
    Med Sci Monit; 2016 Apr; 22():1280-90. PubMed ID: 27086145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase content and activity in low-platelet, low-leukocyte and high-platelet, high-leukocyte platelet rich plasma (PRP) and the biologic response to PRP by human ligament fibroblasts.
    Pifer MA; Maerz T; Baker KC; Anderson K
    Am J Sports Med; 2014 May; 42(5):1211-8. PubMed ID: 24627579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte-Rich Platelet-Rich Plasma Injections Do Not Up-Modulate Intra-Articular Pro-Inflammatory Cytokines in the Osteoarthritic Knee.
    Mariani E; Canella V; Cattini L; Kon E; Marcacci M; Di Matteo B; Pulsatelli L; Filardo G
    PLoS One; 2016; 11(6):e0156137. PubMed ID: 27258008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release kinetics of platelet-derived and plasma-derived growth factors from autologous plasma rich in growth factors.
    Anitua E; Zalduendo MM; Alkhraisat MH; Orive G
    Ann Anat; 2013 Oct; 195(5):461-6. PubMed ID: 23722041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes.
    Dohan Ehrenfest DM; Bielecki T; Mishra A; Borzini P; Inchingolo F; Sammartino G; Rasmusson L; Everts PA
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1131-7. PubMed ID: 21740379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro.
    Schär MO; Diaz-Romero J; Kohl S; Zumstein MA; Nesic D
    Clin Orthop Relat Res; 2015 May; 473(5):1635-43. PubMed ID: 25690170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties.
    El-Sharkawy H; Kantarci A; Deady J; Hasturk H; Liu H; Alshahat M; Van Dyke TE
    J Periodontol; 2007 Apr; 78(4):661-9. PubMed ID: 17397313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects over time of two platelet gel supernatants on growth factor, cytokine and hyaluronan concentrations in normal synovial membrane explants challenged with lipopolysaccharide.
    Ríos DL; López C; Álvarez ME; Samudio IJ; Carmona JU
    BMC Musculoskelet Disord; 2015 Jun; 16():153. PubMed ID: 26092588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An In Vitro Investigation of Platelet-Rich Plasma-Gel as a Cell and Growth Factor Delivery Vehicle for Tissue Engineering.
    Jalowiec JM; D'Este M; Bara JJ; Denom J; Menzel U; Alini M; Verrier S; Herrmann M
    Tissue Eng Part C Methods; 2016 Jan; 22(1):49-58. PubMed ID: 26467221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.